CA2822892C - Procede pour l'inhibition de pathogenes en utilisant une composition nutritionnelle - Google Patents

Procede pour l'inhibition de pathogenes en utilisant une composition nutritionnelle Download PDF

Info

Publication number
CA2822892C
CA2822892C CA2822892A CA2822892A CA2822892C CA 2822892 C CA2822892 C CA 2822892C CA 2822892 A CA2822892 A CA 2822892A CA 2822892 A CA2822892 A CA 2822892A CA 2822892 C CA2822892 C CA 2822892C
Authority
CA
Canada
Prior art keywords
lactoferrin
kcal
human
nutritional composition
source
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2822892A
Other languages
English (en)
Other versions
CA2822892A1 (fr
Inventor
Anja Wittke
Cecilia Munoz
Dattatreya Banavara
Robert J. McMahon
Original Assignee
MJN US Holdings LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/980,813 external-priority patent/US8648036B2/en
Priority claimed from US12/980,808 external-priority patent/US20120171163A1/en
Application filed by MJN US Holdings LLC filed Critical MJN US Holdings LLC
Publication of CA2822892A1 publication Critical patent/CA2822892A1/fr
Application granted granted Critical
Publication of CA2822892C publication Critical patent/CA2822892C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention concerne un procédé pour inhiber un mécanisme bactérien invasif ou d'adhérence impliquant l'administration à un être humain d'une composition nutritionnelle incluant un lipide ou une matière grasse ; une source de protéine ; une composition prébiotique ; et au moins environ 10 mg/100kCal de lactoferrine produite par une source non humaine.
CA2822892A 2010-12-29 2011-12-15 Procede pour l'inhibition de pathogenes en utilisant une composition nutritionnelle Active CA2822892C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12/980,808 2010-12-29
US12/980,813 US8648036B2 (en) 2010-12-29 2010-12-29 Use of nutritional compositions including lactoferrin and one or more prebiotics in inhibiting adhesion of pathogens in the gastrointestinal tract
US12/980,808 US20120171163A1 (en) 2010-12-29 2010-12-29 Method for inhibiting a bacterial invasive mechanism using a nutritional composition
US12/980,813 2010-12-29
PCT/US2011/065231 WO2012091946A2 (fr) 2010-12-29 2011-12-15 Procédé pour l'inhibition de pathogènes en utilisant une composition nutritionnelle

Publications (2)

Publication Number Publication Date
CA2822892A1 CA2822892A1 (fr) 2012-07-05
CA2822892C true CA2822892C (fr) 2020-04-28

Family

ID=45496273

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2822892A Active CA2822892C (fr) 2010-12-29 2011-12-15 Procede pour l'inhibition de pathogenes en utilisant une composition nutritionnelle

Country Status (13)

Country Link
EP (1) EP2658388A2 (fr)
CN (1) CN103327828B (fr)
BR (1) BR112013011642B1 (fr)
CA (1) CA2822892C (fr)
EC (1) ECSP13012798A (fr)
MX (1) MX2013006094A (fr)
MY (1) MY174494A (fr)
PE (1) PE20141192A1 (fr)
PH (1) PH12013500916A1 (fr)
RU (1) RU2013128920A (fr)
SG (2) SG190781A1 (fr)
TW (1) TWI626893B (fr)
WO (1) WO2012091946A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8968722B2 (en) 2010-12-29 2015-03-03 Mead Johnson Nutrition Company Milk-based nutritional compositions containing lactoferrin and uses thereof
WO2014099134A1 (fr) * 2012-12-18 2014-06-26 Mjn U.S. Holdings Llc Compositions nutritionnelles à base de lait contenant de la lactoferrine et ses utilisations
US20140271978A1 (en) * 2013-03-15 2014-09-18 Mead Johnson Nutrition Company Low-buffer nutritional compositions and uses thereof
US9609888B2 (en) * 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
US20200276321A1 (en) * 2017-09-10 2020-09-03 Technion Research & Development Foundation Limited Composition and method for a prebiotic delivery system targeted to probiotic bacteria
GB2618609A (en) * 2022-05-13 2023-11-15 Lintbells Ltd Methods and processes for manufacture of a topically adherent selective bactericide
CN120051217A (zh) 2022-09-14 2025-05-27 N·V·努特里奇亚 营养组合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61701B1 (en) 1986-07-17 1994-11-30 Morinaga Milk Industry Co Ltd Process for producing bovine lactoferrin in high purity
US4977137B1 (en) * 1987-06-03 1994-06-28 Baylor College Medicine Lactoferrin as a dietary ingredient promoting the growth of the gastrointestinal tract
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
CA2101274C (fr) 1991-01-24 1998-12-15 David J. Kyle Melanges d'huiles de microorganismes et leurs usages
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
EP0744901B1 (fr) 1994-02-16 2001-12-05 Pharming Intellectual Property BV Isolation de la lactoferrine du lait
EP1480524B1 (fr) 2002-03-07 2013-04-17 Upfront Chromatography A/S Procede d'isolement de lactoferrine
US20070191264A1 (en) * 2005-05-05 2007-08-16 Bristol-Myers Squibb Company, A Delaware Corporation Methods for inhibiting the growth of bacteria
CN101247823A (zh) * 2005-05-05 2008-08-20 布里斯托尔-迈尔斯斯奎布公司 牛乳铁蛋白在制备抑制细菌生长的药物中的用途
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
WO2008047391A1 (fr) * 2006-10-17 2008-04-24 S.I.F.Fr.A. Farmaceutici Srl Composition nutraceutique comprenant de la lactoferrine et des probiotiques protéasiques
BRPI0819445A2 (pt) * 2007-11-26 2015-12-22 Nestec Sa sistema de nutrição para recém-nascidos adaptado à idade
ITRM20080163A1 (it) * 2008-03-26 2009-09-27 Maurizio Acri Uso della lattoferrina per la prevenzione delle sepsi neonatali in neonati prematuri
US8425955B2 (en) * 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
EP2493336A1 (fr) * 2009-10-29 2012-09-05 Nestec S.A. Compositions nutritionnelles contenant de la lactoferrine et des probiotiques, et nécessaires associés

Also Published As

Publication number Publication date
PH12013500916A1 (en) 2024-06-03
EP2658388A2 (fr) 2013-11-06
CA2822892A1 (fr) 2012-07-05
CN103327828A (zh) 2013-09-25
CN103327828B (zh) 2016-05-11
PE20141192A1 (es) 2014-10-01
ECSP13012798A (es) 2013-09-30
TWI626893B (zh) 2018-06-21
HK1189456A1 (zh) 2014-06-13
MY174494A (en) 2020-04-23
TW201238503A (en) 2012-10-01
BR112013011642B1 (pt) 2020-04-07
WO2012091946A2 (fr) 2012-07-05
WO2012091946A3 (fr) 2012-09-07
SG10201508194RA (en) 2015-11-27
SG190781A1 (en) 2013-07-31
BR112013011642A2 (pt) 2016-07-12
RU2013128920A (ru) 2015-02-10
MX2013006094A (es) 2013-07-03

Similar Documents

Publication Publication Date Title
CA2822892C (fr) Procede pour l'inhibition de pathogenes en utilisant une composition nutritionnelle
US20120172288A1 (en) Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions
US20120171231A1 (en) Use of nutritional compositions including lactoferrin in stimulating immune cells
EP2661180B1 (fr) Composition contenant des protéines de lait thermolabiles et procédé de préparation associé
HK1250608A1 (zh) 包含乳铁蛋白的营养组合物在支持抵抗疾病和状况中的用途
US8648036B2 (en) Use of nutritional compositions including lactoferrin and one or more prebiotics in inhibiting adhesion of pathogens in the gastrointestinal tract
US20120171164A1 (en) Use of nutritional compositions including lactoferrin in supporting resistance to viral respiratory tract infections
US20120171163A1 (en) Method for inhibiting a bacterial invasive mechanism using a nutritional composition
HK1250315A1 (zh) 包含麦芽三糖的组合物及其用於抑制脱水所致损伤的用途
HK1189456B (en) Method for inhibiting pathogens using a nutritional composition
RU2575776C2 (ru) Применение содержащих лактоферрин питательных композиций для стимулирования иммунных клеток
HK1191812A (en) Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20161114

H11 Ip right ceased following rejected request for revival

Free format text: ST27 STATUS EVENT CODE: T-6-6-H10-H11-H101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TIME LIMIT FOR REVERSAL EXPIRED

Effective date: 20240729